| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.075 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |